FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?

2.

RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung

3.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

4.

Males with early-onset colorectal cancer are at risk, according to a study.

5.

Hypnotherapy may offer real benefits for cancer patient care


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot